Weekly epirubicin as salvage therapy in patients with gemcitabine-resistant advanced pancreatic cancer

J Chemother. 2009 Dec;21(6):698-700. doi: 10.1179/joc.2009.21.6.698.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adenocarcinoma / mortality
  • Aged
  • Antibiotics, Antineoplastic / therapeutic use*
  • Deoxycytidine / analogs & derivatives
  • Deoxycytidine / therapeutic use
  • Disease-Free Survival
  • Drug Resistance, Neoplasm
  • Epirubicin / therapeutic use*
  • Female
  • Gemcitabine
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Pancreatic Neoplasms / drug therapy*
  • Pancreatic Neoplasms / mortality
  • Salvage Therapy / methods*

Substances

  • Antibiotics, Antineoplastic
  • Deoxycytidine
  • Epirubicin
  • Gemcitabine